Delays Plague Rivian Spin-out Also’s Innovative E-bike Launch
Rivian’s micromobility spinoff, Also, has encountered significant delays in releasing its anticipated high-tech electric bicycle, the TM-B. Initially slated for spring 2026, customer deliveries remain stalled as the company grapples with complex production challenges.
Unique E-bike Faces Supply Chain Woes
Unveiled last year, the TM-B captured attention with its novel features — including a USB-C rechargeable battery, a removable seat post, and a software-controlled pedal-by-wire system. These innovations, however, have contributed to supply chain difficulties, particularly in securing adequate printed circuit board (PCB) and integrated circuit (IC) materials amidst the ongoing AI boom, as stated by Also’s product manager, Saul Leiken. This shortage has prompted the team to explore alternative materials, necessitating additional engineering and testing efforts.
Technical Challenges and Regulatory Hurdles
The e-bike’s battery, available in 538Wh or 808Wh capacities promising 100 miles of range, poses further complications as its 240W power delivery exceeds current regulatory standards. Consequently, Also is working alongside standards groups to establish new safety protocols, as reported by Leiken.
Moreover, the DreamRide drivetrain system adds to the complexity. This pedal-by-wire mechanism lacks a direct mechanical link between pedalling and vehicle motion. Instead, pedalling powers a generator motor to recharge the battery, which in turn drives a traction motor via a Gates Carbon belt. Achieving the required high-precision manufacturing has contributed to the production slowdown, Leiken acknowledged.
Commitment to Quality and Communication
In a 661-word apology letter shared on Reddit, Leiken underscored Also’s commitment to maintaining stringent quality standards over adhering to initial timelines. He expressed regret for insufficient communication regarding the delays, recognising the importance of keeping customers informed throughout the process. Leiken explained, “As we ramp production, we can relax standards against an original timeline or we can hold to a high standard and face potential delays. We believe our decision to hold that standard was, and is, the right one.”
Reporting based on coverage first published by theverge.com.